Serono Pharma S.p.A. Roma

Part of the The Serono Group: a fully integrated multinational developer and marketer of prescription pharmaceuticals.
World leader in the treatment of reproductive health problems, the company is also active in the therapeutic fields of growth, wasting, multiple sclerosis and immunology/oncology.

Recognizing the enormous potential of recombinant drugs, both in terms of their biological properties and efficacy, we took the decision in the mid-1980s to transform the company into a biotechnology business. This was supported by the establishment and expansion of facilities in the US, Israel and Spain. More recently, we acquired the Serono Pharmaceutical Research Institute (SPRI) in Switzerland, enhancing our capabilities in the field of drug discovery. Over 70% of our sales now come from recombinant products.These recombinant products, such as interferon beta or human growth hormone, will offer novel therapeutic perspectives for life-threatening diseases.

Activity:

- Manufacturing
- Market Research & Marketing
- Research & Development

Product / Technology type(s) covered:

- Bio
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Proteins
- Technology

Therapeutic targets:

- Arthritis / Rheumato
- Cancer
- Gastrointestinal
- Genetics
- Infectious Diseases
- Oncology
- Reproductive Health

Markets Covered

a. HeadQuarter: Switzerland

b. Continent(s) active: Europe , North America , South America , Near/Middle East

c. Countries active:

Corporate data:

Number of Employees: 4500

Turnover:

Amount:	Year:	Currency:
1.38 billion	2001	US Dollar

Year founded: 1906